Tag: Porphyria treatment market
The Porphyria Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
Majority (over 65%) of the abovementioned biologic drugs have been / are being designed for administration via the intravenous route.
0
0
0
14 Jul, 05:35 AM
The porphyria therapies market, Claims Roots Analysis
Majority (over 65%) of the abovementioned biologic drugs have been / are being designed for administration via the intravenous route.
0
0
0
13 Jul, 05:13 AM
Porphyria: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
Close to 20% publications mentioned in the report were focused on the assessment of therapeutics that have been / are being developed for the treatment of erythropoietic protoporphyria
0
0
0
21 Mar, 03:19 AM
The porphyria therapies market is projected to grow at an annualized rate of 10.97% during the period 2021-2030, claims Roots Analysis
Porphyria is a rare disorder that is characterized by excessive accumulation of porphyrin, a compound that aids in the formation of heme
0
0
0
5 Jan, 07:44 AM
